Results 11 to 20 of about 17,265 (194)
PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma [PDF]
Journal of Experimental & Clinical Cancer Research, 2020 Abstract Background Therapeutic options for patients with hepatocellular carcinoma (HCC) are limited. Transarterial chemoembolization (TACE) is an interventional procedure used to deliver chemotherapy and embolizing agents directly to the tumor and is the procedure of choice for patients with intermediate stage HCC.
Sean P. Martin +8 more
openaire +3 more sources
Frontiers in Surgery, 2023 AimTo evaluate the feasibility of the preoperative neutrophil-to-lymphocyte ratio (NLR) as an index to guide postoperative adjuvant transcatheter arterial chemoembolization (PA-TACE) in patients with liver cancer.MethodsWe recruited a total of 166 patients with liver cancer who underwent surgery alone or surgery plus PA-TACE between January 2013 and ...
Guo-Ying Feng +7 more
openaire +3 more sources
Diffusion Kurtosis Imaging for Assessing the Therapeutic Response of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma [PDF]
Journal of Cancer, 2020 Objective: This study aimed to evaluate the therapeutic response of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) with diffusion kurtosis imaging (DKI). Methods: Forty-three patients with fifty-nine hepatic cancer nodules were recruited for this study. All patients were treated by TACE. Magnetic resonance imaging (
Yuan, Zhen-Guo +6 more
openaire +2 more sources
A concise review of updated global guidelines for the management of hepatocellular carcinoma: 2017-2024 [PDF]
Journal of Liver CancerMany guidelines for hepatocellular carcinoma (HCC) have been published and are regularly updated worldwide. HCC management involves a broad range of treatment options and requires multidisciplinary care, resulting in significant heterogeneity in ...
Hyunjae Shin, Su Jong Yu
doaj +1 more source
Open Life Sciences, 2018 Hepatocellular carcinoma is one of the leading causes of cancer-related death. Hepatic transcatheter arterial chemo-embolization (TACE) is commonly used clinically for advanced hepatocellular carcinoma treatment.
Wu Tao +7 more
doaj +1 more source
Management strategies for advanced hepatocellular carcinoma with portal vein tumor thrombosis [PDF]
The Ewha Medical JournalHepatocellular carcinoma with portal vein tumor thrombosis presents a significant therapeutic challenge due to its poor prognosis and limited treatment options.
Jeayeon Park, Su Jong Yu
doaj +1 more source
Cancer Medicine, 2023 Aims To investigate the efficacy and safety of lenvatinib and idarubicin‐loaded drug‐eluting beads transarterial chemoembolization (IDADEB‐TACE) in primary advanced hepatocellular carcinoma (HCC).
Wenzhe Fan +11 more
doaj +1 more source
Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study [PDF]
Journal of Liver Cancer, 2023 Background/Aim To evaluate the applicability of transarterial chemoembolization (TACE) treatment with doxorubicin drug-eluting beads (DEBs) in advanced hepatocellular carcinoma (HCC) patients with portal vein invasion (PVI).
Su Jong Yu +7 more
doaj +1 more source
World Journal of Gastroenterology, 2016 Hepatocellular carcinoma (HCC) is one of the major causes of morbidity and mortality in patients with chronic liver disease. Transarterial chemoembolization (TACE) can significantly improve the survival rate of patients with HCC and is the first treatment choice for patients who are not suitable for surgical resections.
Ke, Yang +4 more
openaire +2 more sources
Evaluation of the Therapeutic Effect of Adjuvant Transcatheter Arterial Chemoembolization Based on Ki67 After Hepatocellular Carcinoma Surgery [PDF]
Frontiers in Oncology, 2021 Background and aimsThis study aimed to determine the relationship between Ki67 expression and the efficacy of postoperative adjuvant transcatheter arterial chemoembolization (PA-TACE) in patients with hepatocellular carcinoma.MethodsThe Kaplan-Meier method was used to analyze the recurrence-free survival (RFS) and overall survival (OS) rates between ...
Yu-Fei Zhao +5 more
openaire +3 more sources